May Cho

2.0k total citations
57 papers, 834 citations indexed

About

May Cho is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, May Cho has authored 57 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 21 papers in Surgery and 15 papers in Pathology and Forensic Medicine. Recurrent topics in May Cho's work include Colorectal Cancer Treatments and Studies (16 papers), Genetic factors in colorectal cancer (13 papers) and Pancreatic and Hepatic Oncology Research (11 papers). May Cho is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Genetic factors in colorectal cancer (13 papers) and Pancreatic and Hepatic Oncology Research (11 papers). May Cho collaborates with scholars based in United States, Canada and China. May Cho's co-authors include Jun Gong, Marwan Fakih, Daneng Li, Andrew Hendifar, Ravi Salgia, Sunil Sharma, Rebecca S. Allen, Chongkai Wang, Ching Ouyang and Arta M. Monjazeb and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

May Cho

55 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May Cho United States 17 507 222 178 175 156 57 834
Kohei Shigeta Japan 15 590 1.2× 210 0.9× 260 1.5× 83 0.5× 139 0.9× 75 945
Martina Valgiusti Italy 17 430 0.8× 217 1.0× 162 0.9× 148 0.8× 202 1.3× 55 896
Jian-Ming Xu China 12 578 1.1× 341 1.5× 98 0.6× 152 0.9× 167 1.1× 15 818
Alexis D. Leal United States 15 545 1.1× 128 0.6× 163 0.9× 188 1.1× 244 1.6× 57 888
Zhifang Jia China 19 312 0.6× 232 1.0× 207 1.2× 77 0.4× 329 2.1× 57 953
Hideki Ueno Japan 14 389 0.8× 140 0.6× 135 0.8× 83 0.5× 192 1.2× 44 706
Javier Ros Spain 17 573 1.1× 177 0.8× 84 0.5× 232 1.3× 203 1.3× 72 798
Kian Fong Foo Singapore 13 320 0.6× 238 1.1× 193 1.1× 78 0.4× 141 0.9× 24 712

Countries citing papers authored by May Cho

Since Specialization
Citations

This map shows the geographic impact of May Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Cho more than expected).

Fields of papers citing papers by May Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Cho. The network helps show where May Cho may publish in the future.

Co-authorship network of co-authors of May Cho

This figure shows the co-authorship network connecting the top 25 collaborators of May Cho. A scholar is included among the top collaborators of May Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May Cho. May Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jingjing, Farshid Dayyani, Jason A. Zell, et al.. (2024). Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer. Journal of Surgical Research. 299. 343–352.
2.
Huynh, Jasmine C., et al.. (2023). Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma. Investigational New Drugs. 42(1). 35–43. 9 indexed citations
3.
Dayyani, Farshid, et al.. (2023). Medullary carcinoma of the duodenum treated with pembrolizumab: a case report. Journal of Gastrointestinal Oncology. 14(2). 1149–1154. 3 indexed citations
4.
Amersi, Farin, Andrew Hendifar, Alexandra Gangi, et al.. (2023). POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval. Genes. 14(5). 1054–1054. 5 indexed citations
5.
Snyder, Rebecca A., Barbara Burtness, May Cho, et al.. (2023). The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership. JNCI Journal of the National Cancer Institute. 115(10). 1132–1138. 2 indexed citations
6.
Judge, Sean J., Michael J. Cavnar, Michael E. Lidsky, et al.. (2023). Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network. Annals of Surgical Oncology. 30(12). 7362–7370. 11 indexed citations
7.
Dayyani, Farshid, et al.. (2022). BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms. Cancers. 14(10). 2453–2453. 17 indexed citations
8.
Cavnar, Michael J., Michael E. Lidsky, Ismael Domínguez-Rosado, et al.. (2022). Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network. HPB. 24(12). 2104–2111. 14 indexed citations
9.
Gholami, Sepideh, et al.. (2022). Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting. Journal of Gastrointestinal Cancer. 54(2). 672–676. 2 indexed citations
10.
Waters, Kevin, Andrew Hendifar, Arsen Osipov, et al.. (2021). Complete response to neoadjuvant pembrolizumab and capecitabine in microsatellite stable, Epstein-Barr virus-positive, locally advanced gastric adenocarcinoma: case report. AME Case Reports. 5. 30–30. 3 indexed citations
11.
Zimmermann, Maike, Tao Li, Thomas J. Semrad, et al.. (2020). Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy. Molecular Cancer Therapeutics. 19(4). 1070–1079. 20 indexed citations
12.
Kim, Sungjin, Timothy P. DiPeri, Michelle Guan, et al.. (2020). Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. World Journal of Gastrointestinal Surgery. 12(9). 377–389. 6 indexed citations
13.
Fakih, Marwan, Ching Ouyang, Chongkai Wang, et al.. (2019). Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. Journal of Clinical Investigation. 129(10). 4464–4476. 62 indexed citations
14.
Gong, Jun, Edward Kim, Marwan Fakih, et al.. (2019). Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clinical Colorectal Cancer. 18(4). 307–309. 10 indexed citations
15.
Chen, Haihui, Haixin Huang, Megan E. Daly, et al.. (2019). Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Practical Radiation Oncology. 10(5). e372–e377. 11 indexed citations
16.
Gong, Jun, et al.. (2017). A single institution experience with palbociclib toxicity requiring dose modifications. Breast Cancer Research and Treatment. 168(2). 381–387. 35 indexed citations
17.
Cho, May, Jonathan Kessler, John J. Park, et al.. (2017). A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres® versus SIR-Spheres® alone in chemotherapy-resistant colorectal cancer liver metastases. Journal of Gastrointestinal Oncology. 8(4). 608–613. 6 indexed citations
18.
Cho, May, Jun Gong, & Marwan Fakih. (2015). The state of regional therapy in the management of metastatic colorectal cancer to the liver. Expert Review of Anticancer Therapy. 16(2). 229–245. 6 indexed citations
19.
Cho, May, Andrea Wang‐Gillam, Robert J. Myerson, et al.. (2015). A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma. HPB. 17(7). 587–593. 12 indexed citations
20.
Cho, May, Yuanlin Dong, Eun-Sook Lee, et al.. (2013). Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells. Journal of Cancer. 4(8). 671–678. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kohei Shigeta Breakdown of academic impact, for papers by Martina Valgiusti Breakdown of academic impact, for papers by Jian-Ming Xu Breakdown of academic impact, for papers by Alexis D. Leal Breakdown of academic impact, for papers by Zhifang Jia Breakdown of academic impact, for papers by Hideki Ueno Breakdown of academic impact, for papers by Javier Ros Breakdown of academic impact, for papers by Kian Fong Foo
Rankless by CCL
2026